Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 4.18% is 50% below its 5-year average of 8.39%, around the middle of its 5-year range (-123.36%–127.88%).
28.87% below its 12-month average of 5.88%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 4.61%.
OPERATING MARGIN
4.18%
OPERATING MARGIN AVG TTM
5.88%
OPERATING MARGIN AVG 3Y
4.22%
OPERATING MARGIN AVG 5Y
8.39%
OPERATING MARGIN AVG 10Y
8.14%
OPERATING MARGIN AVG 15Y
7.93%
OPERATING MARGIN AVG 20Y
9.10%
CURRENT VS TTM AVG
-28.87%
CURRENT VS 3Y AVG
-0.85%
CURRENT VS 5Y AVG
-50.18%
CURRENT VS 10Y AVG
-48.65%
CURRENT VS 15Y AVG
-47.26%
CURRENT VS 20Y AVG
-54.09%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 598 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Integra LifeSciences Holdings Corporation
Market Cap
$1.01B
Operating Margin
4.18%
TTM Avg
5.88%
3Y Avg
4.22%
5Y Avg
8.39%
Market Cap
$1.00B
Operating Margin
-1576.67%
TTM Avg
-1255.13%
3Y Avg
-1048.04%
5Y Avg
-849.59%
Market Cap
$1.01B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-59.79%
Market Cap
$1.01B
Operating Margin
-377.11%
TTM Avg
-200.94%
3Y Avg
-143.24%
5Y Avg
-174.04%
Market Cap
$1.02B
Operating Margin
1.38%
TTM Avg
4.21%
3Y Avg
3.61%
5Y Avg
3.61%
Market Cap
$987.45M
Operating Margin
-1149.52%
TTM Avg
-2324.93%
3Y Avg
-1162.47%
5Y Avg
-1162.47%
Market Cap
$987.11M
Operating Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$982.12M
Operating Margin
-130.20%
TTM Avg
-311.82%
3Y Avg
-583.08%
5Y Avg
-487.88%
Market Cap
$975.87M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Integra LifeSciences Holdings Corporation (IART) | $1.01B | 4.18% | 5.88% | 4.22% | 8.39% |
| Janux Therapeutics, Inc. (JANX)vs › | $1.00B | -1576.67% | -1255.13% | -1048.04% | -849.59% |
| Cullinan Therapeutics, Inc. (CGEM)vs › | $1.01B | 0.00% | 0.00% | 0.00% | -59.79% |
| Immatics N.V. (IMTX)vs › | $1.01B | -377.11% | -200.94% | -143.24% | -174.04% |
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI)vs › | $1.02B | 1.38% | 4.21% | 3.61% | 3.61% |
| Aktis Oncology, Inc. (AKTS)vs › | $987.45M | -1149.52% | -2324.93% | -1162.47% | -1162.47% |
| Latigo Biotherapeutics Inc. (LTGO)vs › | $987.11M | N/A | N/A | N/A | N/A |
| MeiraGTx Holdings plc (MGTX)vs › | $982.12M | -130.20% | -311.82% | -583.08% | -487.88% |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $975.87M | 0.00% | 0.00% | 0.00% | 0.00% |
| Teladoc Health, Inc. (TDOC)vs › | $1.05B | -6.98% | -25.06% | -156.73% | -114.38% |
Gross Margin
53.7%
Operating Margin
4.2%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 4.61% |
| 2026-03-31 | 10.23% |
| 2025-12-31 | 127.88% |
| 2025-09-30 | 10.02% |
| 2025-06-30 | -123.36% |
| 2025-03-31 | -4.05% |
| 2024-12-31 | 8.05% |
| 2024-09-30 | -2.14% |
| 2024-06-30 | -0.72% |
| 2024-03-31 | 1.07% |
| 2023-12-31 | 9.08% |
| 2023-09-30 | 6.95% |
| 2023-06-30 | 3.28% |
| 2023-03-31 | 9.55% |
| 2022-12-31 | 17.04% |
| 2022-09-30 | 16.89% |
| 2022-06-30 | 15.05% |
| 2022-03-31 | 12.26% |
| 2021-12-31 | 14.36% |
| 2021-09-30 | 14.59% |
| 2021-06-30 | 13.30% |
| 2021-03-31 | 8.53% |
| 2020-12-31 | 13.55% |
| 2020-09-30 | 15.54% |
| 2020-06-30 | 5.44% |
| 2020-03-31 | 7.65% |
| 2019-12-31 | 9.13% |
| 2019-09-30 | -5.43% |
| 2019-06-30 | 11.98% |
| 2019-03-31 | 8.98% |
| 2018-12-31 | 8.90% |
| 2018-09-30 | 6.47% |
| 2018-06-30 | 7.55% |
| 2018-03-31 | 7.16% |
| 2017-12-31 | 1.96% |
| 2017-09-30 | 3.82% |
| 2017-06-30 | 6.02% |
| 2017-03-31 | 3.85% |
| 2016-12-31 | 15.95% |
| 2016-09-30 | 12.02% |
| 2016-06-30 | 8.98% |
| 2016-03-31 | 9.34% |
| 2015-12-31 | 9.96% |
| 2015-09-30 | 4.41% |
| 2015-06-30 | 5.72% |
| 2015-03-31 | 7.18% |
| 2014-12-31 | 10.58% |
| 2014-09-30 | 7.72% |
| 2014-06-30 | 5.36% |
| 2014-03-31 | 4.06% |
| 2013-12-31 | 8.17% |
| 2013-09-30 | -13.89% |
| 2013-06-30 | 3.88% |
| 2013-03-31 | -0.02% |
| 2012-12-31 | 8.65% |
| 2012-09-30 | 9.39% |
| 2012-06-30 | 8.57% |
| 2012-03-31 | 8.90% |
| 2011-12-31 | 3.81% |
| 2011-09-30 | 9.05% |
| 2011-06-30 | 4.14% |
| 2011-03-31 | 11.53% |
| 2010-12-31 | 12.45% |
| 2010-09-30 | 14.63% |
| 2010-06-30 | 13.76% |
| 2010-03-31 | 13.11% |
| 2009-12-31 | 15.17% |
| 2009-09-30 | 13.83% |
| 2009-06-30 | 14.42% |
| 2009-03-31 | 13.83% |
| 2008-12-31 | 14.32% |
| 2008-09-30 | -13.70% |
| 2008-06-30 | 15.78% |
| 2008-03-31 | 13.16% |
| 2007-12-31 | 9.87% |
| 2007-09-30 | 13.58% |
| 2007-06-30 | 12.54% |
| 2007-03-31 | 13.41% |
| 2006-12-31 | 16.07% |
| 2006-09-30 | 10.13% |
| 2006-06-30 | 13.14% |
| 2006-03-31 | 17.66% |
| 2005-12-31 | 20.43% |
| 2005-09-30 | 23.21% |
| 2005-06-30 | 17.40% |
| 2005-03-31 | 19.68% |
| 2004-12-31 | 22.05% |
| 2004-09-30 | -20.60% |
| 2004-06-30 | 20.55% |
| 2004-03-31 | 22.37% |
| 2003-12-31 | 22.02% |
| 2003-09-30 | 23.21% |
| 2003-06-30 | 19.40% |
| 2003-03-31 | 20.23% |
| 2002-12-31 | 22.55% |
| 2002-09-30 | 5.27% |
